Sam Houston state developing lab test for bath salts

October 25, 2012

Sam Houston State University is developing a laboratory test to detect the use of bath salts, a new designer drug that was added to the list of illegal substances by the Drug Enforcement Administration in 2011.

Sam Houston State University received a federal grant from the National Institute of Justice to create a test for key components of in in crime labs.

Bath salts, also known as synthetic cathinones, were legally sold in convenience stores, head shops and on the Internet until being included on the list of through an emergency order by the Enforcement Administration in October 2011. These drugs, that are capable of producing powerful hallucinogenic and adrenergic effects, are routinely seized in drug cases around the Houston metropolitan area and throughout the nation.

"Bath salts are the new breed of designer amphetamines, and they pose a number of challenges for from a public safety and public health standpoint," said Sarah Kerrigan, Director of the Forensic Science Program at Sam Houston State University.

According to the , bath salts also have adverse effects including rapid which may lead to heart attacks and strokes, chest pains, nosebleeds, sweating, nausea, and vomiting. Those who abuse the substance also report agitation, insomnia, irritability, dizziness, depression, paranoia, delusions, suicidal thoughts, seizures, and panic attacks.

According to a 2011 report from the National Drug Intelligence Center, drug users are attracted to bath salts because they can evade most drug tests and, as a result, it may not be detected in impaired driving cases or death investigations.

"Analytical limitations for state and local forensic toxicology laboratories impact criminal and death investigation casework, and these deficiencies can have serious criminal justice consequences," Kerrigan said.

While bath salts are easy to detect in seized samples, such as pills, powders and capsules, once they are ingested, they pose a number of challenges in the toxicology lab. The Department of Forensic Science will develop a procedure to detect at least eight of the most common components found in bath salts in biological evidence. These components include mephedrone, flephedrone, methylone , butylone, ethylone, methedrone, MDPV, and naphyrone.

Many toxicology labs use gas chromatography-mass spectrometry (GC/MS) to identify drugs in biological evidence. The new study will target a wide variety of the new designer drugs using one procedure.

Explore further: Researchers tackle designer drug craze

Related Stories

Researchers tackle designer drug craze

July 16, 2012
(Medical Xpress) -- President Obama signed a bill into law this week designating certain chemicals found in designer drugs as FDA-controlled substances.

Bath salts emerging as new recreational drugs

October 24, 2011
The use of bath salts as recreational drugs has greatly escalated in recent years. Researchers from the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma describe an incident of a man experiencing significant ...

US 'bath salts' ban aimed at violence-linked drugs

July 25, 2012
(AP) — People are inventing so many new, legal ways to get high that U.S. lawmakers can't seem to keep up.

Recommended for you

Fighting opioid addiction in primary care—new study shows it's possible

October 18, 2017
For many of the 2 million Americans addicted to opioids, getting good treatment and getting off prescription painkillers or heroin may seem like a far-off dream.

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.